Elevance Health (ELV): Director sold ~$7.5K

~$7.5K

Approx. value · 26 sh @ $287.50

218

Holds after · shares reported

Traded

Mar 12, 2026

Filed

Mar 23, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Dec 29, 2025CongressDisclosed purchase of ELV — reported range $15,001 - $50,000
2. Jan 28, 2026Company filing · Form 8-K · ResultsReported its results
3. Feb 26, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On February 26, 2026, Elevance Health, Inc. (the “Company”) announced certain management changes. Among these changes, Peter D. Haytaian will transition from his role as Executive Vice President and President of Carelon, effective May 4, 2026, to devote more time to family commitments.”
4. Mar 5, 2026Insider · Their first buy on recordDirector purchased ~$870K of ELV shares in the open market
5. Mar 6, 2026InsiderOfficer sold ~$911K of ELV shares in the open market
6. Mar 12, 2026 · this disclosureInsiderDirector sold ~$7.5K of ELV shares in the open market

What came next

1. Mar 26, 20265% stakeThe Vanguard Group reported a passive stake (13G)
2. Apr 22, 2026Company filing · Form 8-K · ResultsReported its results
3. Apr 29, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.1%
4. May 19, 2026InsiderOfficer sold ~$617K of ELV shares in the open market
5. Jun 11, 2026InsiderDirector sold ~$61K of ELV shares in the open market
6. Jun 12, 2026InsiderOfficer sold ~$149K of ELV shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Elevance Health

For Elevance Health, OQRO holds 16 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ELV page.

Other recent filings by Amy W Schulman, Director

• SEC Form 4 at Alnylam Pharmaceuticals (ALNY)Nov 12, 2026
• SEC Form 4 at Fractyl Health (GUTS)Mar 17, 2025

The full history of Amy W Schulman, Director is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Elevance Health

• SEC Form 4Nov 6, 2026
• SEC Form 144Nov 5, 2026
• SEC Form 4Oct 23, 2026
• SEC Form 4Oct 23, 2026
• SEC Form 4Oct 23, 2026
• SEC Form 4Oct 23, 2026

Everything OQRO holds on this company is on its ELV page.